Nuclera

Sign up today for 26th July webinar, to hear CTO Gordon McInroy PhD discuss rapid active protein access using the eProtein Discovery system nuclera.com/webinars-event… #proteinexpression #solubleprotein

We are honored and delighted to welcome synthetic biology leader Professor Michael Jewett as a distinguished member to our Scientific Advisory Board! Dr. Jewett brings Nuclera subject matter expertise on harnessing cell free protein synthesis technologies bit.ly/3yYt95S

We're delighted to announce that we received the @businessweekly Tech Scale-up of the Year Award. 2022 has brought our eProtein bioprinter into select labs enabling their access to proteins which is a key milestone on our path to our launch. bit.ly/3S2KRfP

Welcome to @synsenso_eu - a new @mscactions doctoral network led by @synbiocentre @tudarmstadt, set out to develop new combinatorial #biosensors. Visit our website to find out more 👇 @HorizonEU #MSCA #DN 🧬

We are so thrilled to have Dr. Colin Barnes on our Executive Leadership Team as our VP of Intellectual Property. Read more about Colin's career and his pivotal role in the commercialization of early sequencing technology. bit.ly/3x7VLZG

We are honored to be shortlisted for the @businessweekly awards #BusinessWeeklyAwards

@RhysLindmark @DNAScript @molassemblies Our @jiahao28 is here!

I'm sad none of the founders of enzymatic DNA synthesis companies are on Twitter. 😢 @dnascript @molassemblies @nuclera where y'all at?!? 😜

Proteins are key for drug discovery. The startup @nuclera has worked on bringing a desktop 3D protein printer to market since 2013, to help scientists do their research. Now with a €38m raise, it can do it. @AmadeusCapital @EInk #Biotechnology @siftedeu sifted.eu/articles/nucle…

Nuclera raises $42.5M in first close of Series B for desktop protein printer nuclera.com/latest-news/nu…

@BuiltWithBio @EInk

Nuclera announces expansion with new US subsidiary nuclera.com/latest-news/nu… #desktopbioprinting #makebiologyaccessible

We are #expanding! Check out a range of job openings in #software, #finance, #engineering and #biology. See how you can help us launch our desktop bioprinter: apply.workable.com/nuclera/

🧬🔬👍👍

Warm congratulations to Prof Shankar Balasubramanian for winning the 2021 Breakthrough prize for next-generation sequencing. Shankar is a scientific mentor to our very own Michael & Gordon. bit.ly/3nho1VC

With the right team and today’s technology, there are no limitations. @Nuclera and @EInk have made biology accessible together through digital microfluidics. blog.eink.com/nuclera-deskto…

We look forward to continuing our fruitful collaboration with @EInk to #makebiologyaccessible for all!

@Edzer_EInk @EInk Eager to work together!

Exciting news as we announced our work with @Nuclera to make #biology accessible through digital microfluidics - an exciting development for #science & #tech! @EInk digitimes.com/news/a20210514…

Now on Clubhouse, we have Michael Chen of @nuclera, which is combining enzymatic DNA synthesis, digital microfluidics, and protein synthesis in a desktop bioprinter. They are on a mission to make biology more accessible. Join the discussion now! #synbio joinclubhouse.com/join/synthetic…

Join us TODAY at 8 am PT for Built with Biology: Cheese and AI! Check out this week’s expert speakers: @KocerDilek and @CommsMattr of @motiffoodworks, @nikhitasingh of @Artificial__Inc and Michael Chen of @nuclera #synbio #AI #plantbased joinclubhouse.com/join/synthetic…

Thank you @TaylorWessingUK For you support! taylorwessing.com/en/insights-an…